I think Antibotter is right. If we read between the lines, Jackie announces her retirement in 2024, then remains as a consultant to her replacement for 12 months.....so will be with us until the end of 2025 probably.
In between we're expecting the results of the UK Viraleze as a treatment trial plus Phase 2 DEP results before the end of 2023.....so the development phase of SPL's business will be complete.....that was Jackie's job
Then we can expect a new CEO, probably a commercial CEO, to take the helm Previously only a scientific CEO had the knowledge to take the helm. Read between lines, good times ahead!
SPL Price at posting:
41.0¢ Sentiment: Hold Disclosure: Held
